Sidebar
The United States is projected to hold about $21 trillion in debt in 2021, and that number is expected to ...
Total number of deaths in each category from 1999 through 2016 are shown in the upper left corner of each ...
In an ideal world, the price of a vial of vaccine would be consistent across the globe. But at this ...
How can we best mitigate future pandemic waves while limiting collateral economic damage? As COVID-19 social distancing measures are relaxed ...
If there is any doubt whether COVID-19 has changed the economy, simply look at the investment allocations for healthcare. The ...
More transmissible variants and slower rollout of vaccines increase downside risk to herd immunity timeline. Issues include manufacturing and supply ...
Cell and gene therapies offer treatment, and sometimes cures, for patients with serious, often rare, and never-before-addressed diseases. And many ...
Systems thinking can help policymakers understand and influence the spread of infection and its multifaceted consequences across the community since ...
COVID-19 Projections machine learning team cites the following notes in their live analysis of herd immunity in the United States. ...
We have an opportunity to reach the peak of this current wave by the end of January if we can ...
Europe seems to have turned the corner on their most recent upswing in cases. But if past patterns hold true, ...
Cases in the United States are increasing, and increasing at an unprecedented rate - portending an increase in the number ...
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy